Abstract
Is colchicine effective for secondary prevention in cardiovascular (CV) disease? Daily low-dose colchicine lowers the risk of CV events in people with coronary artery disease (CAD) by about 1% per year (a relative risk reduction [RRR] of about 30%) but raises the risk of gastrointestinal events by
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
